Search

Showing total 5 results
Start Over Language polish Journal przeglad epidemiologiczny Region europe
5 results

1. "Health 2020"--new framework for health policy. Part I.

Author

Opolski JT and Wysocki MJ

Subjects
Europe, Government Agencies organization & administration, Humans, International Cooperation, Leadership, Poland, Socioeconomic Factors, World Health Organization, Delivery of Health Care organization & administration, Health Care Sector organization & administration, Health Policy, Health Promotion organization & administration, Health Status Disparities, National Health Programs organization & administration
Abstract

The paper presents the new framework for health policy adopted in September 2012 during the 62nd session of World Health Organization (WHO) Regional Committee for Europe as the strategy "Health 2020". Four priority areas for policy action as well as prerequisites for achieving two interlinked strategic objectives; improving health for all and reducing health inequalities as well as improving leadership and participatory governance for health are presented and discussed.

Published
2013

2. "Health 2020"--new framework for health policy. Part II.

Author

Opolski JT and Wysocki MJ

Subjects
Congresses as Topic, Europe, Government Agencies organization & administration, Humans, International Cooperation, Leadership, Poland, Socioeconomic Factors, World Health Organization, Delivery of Health Care organization & administration, Health Care Sector organization & administration, Health Policy, Health Priorities organization & administration, Health Promotion organization & administration, Health Status Disparities, National Health Programs organization & administration
Abstract

The papers continues presentation of the new framework for health policy related to "Health 2020" strategy adopted in September 2012 unanimously by all member countries of EURO Region during the 62nd session of the World Health Organization Regional Committee for Europe. Four priority areas for action are presented.

Published
2013

3. [Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively].

Author

Kozielewicz D, Halota W, and Dybowska D

Subjects
Carrier Proteins, Clinical Trials, Phase III as Topic, Drug Administration Schedule, Drug Resistance, Viral drug effects, Drug Therapy, Combination, Europe, Humans, Intracellular Signaling Peptides and Proteins, Poland, Proline therapeutic use, Ribavirin therapeutic use, Treatment Outcome, Viral Nonstructural Proteins, Antiviral Agents therapeutic use, Hepacivirus drug effects, Hepatitis C, Chronic drug therapy, Oligopeptides therapeutic use, Proline analogs & derivatives, Serine Proteinase Inhibitors therapeutic use
Abstract

Since ten years pegylated interferon alpha and ribavirin (PR) are a standard treatment for the patients with chronic HCV infection. Recently, new drugs emerge called direct-acting antivirals. The first of them, telaprevir (TVR) and boceprevir (BOC), which peptidomimetic NS3/4A HCV serine protease inhibitors, have been recorded this year in Europe. Adding them to the PR significantly increases efficacy of standard treatment and creates the possibility of its reduction. This paper presents, based on the results of the third phase studies, the efficacy of triple therapy in selected groups of patients. Also includes current recommendations for treatment with BOC or TVR in combination with PR.

Published
2012

4. [Epidemiologic situation of Lyme borreliosis in Europe].

Author

Flisiak R and Zabicka J

Subjects
Adult, Animals, Antibodies, Bacterial analysis, Arachnid Vectors microbiology, Borrelia burgdorferi Group isolation & purification, Europe epidemiology, Forestry, Humans, Lyme Disease immunology, Lyme Disease transmission, Middle Aged, Occupational Diseases epidemiology, Population Surveillance, Prevalence, Seroepidemiologic Studies, Lyme Disease epidemiology
Abstract

The aim of paper was to present epidemiological data related to Lyme borreliosis (LB), including reservoirs and transmission of Borrelia burgdorferi (B.b.). Incidence of the disease in Europe was evaluated through review of literature data. Morbidity exceeding 100 cases per 100,000 inhabitants per year observed in central Europe, indicate the highest prevalence of LB in this part of continent. Prevalence of antibodies against B.b. among blood donors in particular european countries varied from 0 to 18.8%, whereas in high risk groups (mostly forestry workers) it was 5.7-71%. Diagnostical criterions for surveillance purpose in Europe, which should be established in future, make possible to complete epidemiological data related to LB.

Published
1995

5. [The role of ticks in the epidemiology of Lyme borreliosis].

Author

Wegner Z and Stańczak J

Subjects
Animals, Bites and Stings prevention & control, Disease Reservoirs, Europe epidemiology, Host-Parasite Interactions, Humans, Lyme Disease prevention & control, Lyme Disease transmission, Arachnid Vectors, Lyme Disease epidemiology, Ticks physiology
Abstract

In this paper the current knowledge of the natural circulation of Borrelia burgdorferi, the etiologic agent of Lyme borreliosis, and its relationships both to hard ticks (Ixodidae) serving as vectors, and to certain vertebrates which function as tick hosts and pathogen reservoirs is reviewed. The modes of transmission of borreliae (by salivation, regurgitation, defecation) by ticks to their animal hosts and men as well as prophylactic measures against tick-bites are also discussed.

Published
1995